KP
Insider selling
Kush Parmar sold $807K of Entrada Therapeutics, Inc. (TRDA) stock
Kush Parmar, Dir, 10% of Entrada Therapeutics, Inc. (TRDA), sold 116,474 shares of TRDA stock worth $807K, per an SEC Form 4 filed Aug 3, 2026.
It was an open-market sale.
The trade happened on Jul 30, 2026, 4 days before it was made public.
TRDA has moved -16.2% since the trade date, from $6.77 to $5.67 (Oct 9, 2026 close).
- Traded
- Jul 30, 2026
- Disclosed
- Aug 3, 2026
- Filing delay
- 4 days
- Price since
- -16.2%
- Role
- Dir, 10%
- Source
- SEC Form 4
More TRDA insider and Congress trades
- SellTRDA · Mpm Bioventures 2018, L.P.$1.9MSep 9, 2026
- SellTRDA · Mpm Bioventures 2014, L.P.$1.9MSep 9, 2026
- SellTRDA · Mpm Bioventures 2018, L.P.$617KSep 3, 2026
- SellTRDA · Mpm Bioventures 2014, L.P.$617KSep 3, 2026
- SellTRDA · Mpm Bioventures 2018, L.P.$616KAug 31, 2026
- SellTRDA · Mpm Bioventures 2014, L.P.$616KAug 31, 2026
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.